Biotech · Private company
Serenity Pharmaceuticals, Inc.
Track this companyFree. Adds Serenity Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- SER120Phase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 (1000 ng/day)Phase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 (1500 ng/day)Phase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 (750 ng/day)Phase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 1500 ngPhase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 750 ngPhase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 Nasal Spray 500 ng/dayPhase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
- SER120 nasal spray 750 ng/dayPhase 3 · NocturiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4PHASE3 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01900704 · fetched Nov 12, 2026
- Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With NocturiaPHASE2_PHASE3 · COMPLETED · started May 1, 2011ClinicalTrials.gov NCT01357356 · fetched Nov 12, 2026
- Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With NocturiaPHASE3 · COMPLETED · started Apr 1, 2010ClinicalTrials.gov NCT01259128 · fetched Nov 12, 2026
- Long Term Safety Assessment of SER120 in Patients With NocturiaPHASE3 · COMPLETED · started Aug 1, 2009ClinicalTrials.gov NCT00981682 · fetched Nov 12, 2026
- Treatment of Patients With Nocturia (Non-PK Study)PHASE3 · COMPLETED · started Jun 1, 2009ClinicalTrials.gov NCT00937378 · fetched Nov 12, 2026
- Treatment of Patients With NocturiaPHASE3 · COMPLETED · started Jun 1, 2009ClinicalTrials.gov NCT00937859 · fetched Nov 12, 2026